As U.S. health care costs continue their relentless rise, much of the cost is passed on to insured patients in the form of higher deductibles, copays and coinsurance. The problem has become so acute that physicians have coined the term “financial toxicity” to describe this troubling phenomenon. Financial toxicity increases the likelihood of high debt and bankruptcy, creates barriers to necessary medical care, and forces patients to make trade-offs between medical and nonmedical needs. At this event, we spoke with physician experts in cardiovascular disease and cancer to understand how financial toxicity harms patients in their specialty, and discussed potential solutions that clinicians and policymakers can apply in medical practice to mitigate the burden and consequences of out-of-pocket costs for patients.
8:00 a.m. — Breakfast
8:30 a.m. — Opening Remarks & Introduction
8:40 a.m. — Presentations
9:20 a.m. — Discussion and Q&A
9:50 a.m. — Concluding Remarks
Registration has closed.
Events and webinars are powered by the contributions of our donors and members. Please consider supporting our work by making a gift or joining a membership group. Learn more here or text BAKER to 243725 to give today.
Rola El-Serag, M.D.
L.E. and Virginia Simmons Senior Fellow in Health Policy and Director, Center for Health and Biosciences, Baker Institute
Khurram Nasir, M.D., MPH
Division Chief, Cardiovascular Prevention and Wellness, DeBakey Heart & Vascular Center; Director, Center for Computational Health & Precision Medicine (C3-PH); and Division Chief, Health Equity and Disparities Research and Co-Director, Center for Outcomes Research, Houston Methodist
Anaeze C. Offodile II, M.D., MPH
Nonresident Scholar, Center for Health and Biosciences, Baker Institute; Assistant Professor, Department of Plastic Surgery and Executive Director of Clinical Transformation, The University of Texas MD Anderson Cancer Center
Vivian Ho, Ph.D.
James A. Baker III Institute Chair in Health Economics, Baker Institute